The age old question: who benefits from prostate cancer treatment?

BJU Int. 2014 Jan;113(1):4. doi: 10.1111/bju.12184.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biomarkers, Tumor / blood*
  • Humans
  • Male
  • Prostate-Specific Antigen / blood*
  • Prostatectomy / mortality*
  • Prostatic Neoplasms / mortality*
  • Prostatic Neoplasms / pathology*

Substances

  • Biomarkers, Tumor
  • Prostate-Specific Antigen